Earnings call transcript: Coupang Q1 2026 misses EPS, stock rises By Investing.com

Coupang reported Q1 2026 revenue of $8.5B, up 8% year over year and slightly above the $8.49B forecast, but diluted EPS missed badly at -$0.15 versus -$0.03 expected. Gross margin contracted 230 bps to 27%, reflecting voucher costs and temporary network inefficiencies tied to the prior data incident, while the stock still rose 2.47% after hours to $20.40. Management guided Q2 constant-currency revenue growth of 9%-10% and expects margin pressure to ease over the year, with annual margin expansion resuming next year.

Analysis

The key second-order effect is that this quarter is more about balance-sheet repair of customer behavior than a clean earnings inflection. The market is implicitly choosing to look through the current margin reset because the recovery in active behavior should mechanically improve unit economics over the next 2-3 quarters as fixed logistics capacity re-rates toward better utilization; that argues for a staged margin recovery rather than a V-shape. The risk is that investors extrapolate the revenue recovery too quickly while underestimating how long the company will carry stranded cost and elevated tax drag, which can keep reported EPS noisy even if operating trends improve.

Competitive dynamics likely tilt in Coupang’s favor if the recovery holds, because large-scale logistics networks are easier to leverage than to rebuild. If WOW reactivations continue and new signups normalize, smaller Korean marketplaces and cross-border entrants should see less room to pry away high-frequency customers, while the main pressure point becomes pricing and subsidized delivery rather than customer acquisition. In Taiwan and Japan, the more interesting implication is not current losses but option value: once last-mile density crosses a threshold, the same infrastructure can create a much steeper margin step-up than the market is likely modeling today.

The contrarian view is that consensus may be overpaying for “transitory” margin pain just as the stock already discounts a lot of recovery. If the market is right that 2026 turns profitable, the current multiple can compress quickly; but if there is even a modest delay in returning utilization to plan, the stock remains vulnerable because the valuation is still growth-stock expensive relative to near-term earnings power. In practice, this makes the next two print cycle windows the key catalyst period: beats on engagement and Q2 margin stability should support the name, while any sign of slower reactivation or more persistent network inefficiency would unwind the aftermarket optimism fast.

Key Decisions for Investors

• Long CPNG into the next 1-2 earnings prints as a recovery trade, but size modestly; upside comes from multiple expansion if active-customer and margin trends stabilize, while downside is limited if management continues to prove the dislocation is temporary.
• Buy CPNG Jan-2027 call spreads to express recovery without paying full multiple risk; structure around a strike zone that monetizes a return to normalized EBITDA margin, with thesis duration 6-12 months.
• Pair trade: long CPNG / short a U.S. broadline retail or marketplace name with less fixed-cost leverage to demand recovery; this isolates the benefit of reacceleration while hedging consumer-spending beta.
• Take profit on any sharp post-earnings bounce above recent trading range; the stock can remain range-bound until the market sees at least one clean quarter of sequential margin improvement, not just improving commentary.
• Monitor Taiwan/Japan updates as a separate optionality catalyst; if management signals faster-than-expected unit economics there, add on weakness because that would extend the valuation runway beyond the Korea recovery story.